Worth Financial Advisory Group, LLC Johnson & Johnson Transaction History

Worth Financial Advisory Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$155.22 - $162.74 $443,929 - $465,436	2,860 Added 24.14%	14,708 $2.33 Billion
Q4 2023 Jan 19, 2024	BUY	$145.6 - $158.88 $45,281 - $49,411	311 Added 2.7%	11,848 $1.86 Billion
Q3 2023 Oct 13, 2023	BUY	$155.75 - $174.48 $84,416 - $94,568	542 Added 4.93%	11,537 $1.8 Billion
Q2 2023 Jul 28, 2023	SELL	$154.35 - $166.11 $211,305 - $227,404	-1,369 Reduced 11.07%	10,995 $1.82 Billion
Q1 2023 Apr 19, 2023	BUY	$151.05 - $180.26 $172,801 - $206,217	1,144 Added 10.2%	12,364 $1.92 Billion
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $1.8 Million - $2.02 Million	11,220 New	11,220 $1.98 Billion

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Worth Financial Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Financial Advisory Group, LLC with notifications on news.